Protein-tyrosine phosphatase (PTP) inhibitors are potent activators of T lymphocytes, most likely by affecting the early steps of T cell receptor (TCR) signaling. We have analyzed the effect of the PTP inhibitor bisperoxovanadium (bpV) on expression of the human cyclooxygenase 2 (COX-2) gene, which is induced following TCR triggering. Here we show that COX-2 promoter activity is markedly up-regulated following exposure of Jurkat T cells to bpV(pic). Interestingly enough, treatment of Jurkat cells with cyclic AMP-elevating agents such as forskolin, in combination with bpV, resulted in a more important COX-2 transcriptional activation. Such activation is inhibited by the immunosuppressive drugs FK506 and cyclosporin A. The two nuclear factor of activated T cells (NFAT) binding sites located within the COX-2 promoter region are involved in bpV-mediated positive effect on COX-2 promoter. Electromobility shift assays showed that NFAT1 and activator protein-1 are both translocated to the nucleus following bpV treatment. The active participation of p56 lck , ZAP-70, p36 LAT , and calcium in the bpV-dependent signaling cascade leading to COX-2 transcriptional activation was demonstrated using deficient cell lines and specific inhibitors. Although several PTPs are most likely targeted by bpV, our data suggest that the bpV-mediated signaling cascade is initiated by inhibition of SHP-1, which leads to phosphorylation of p56 lck and ZAP-70 and, ultimately, to NFAT and activator protein-1 nuclear translocation. These results suggest that PTP inhibitors can activate COX-2 gene expression in a manner very similar to the stimulation induced by TCR triggering.Prostaglandins are important mediators in many physiological processes including cell growth, ovulation, and immune functions. These potent lipid molecules play key roles in the inflammatory response, and inhibition of their synthesis is the target of most non-steroidal anti-inflammatory drugs. Prostaglandin biosynthesis is controlled by the cyclooxygenase (COX) 1 enzyme, which catalyzes the initial conversion of arachidonic acid to prostaglandin H 2 , a precursor common to all prostanoids. Two COX isoenzymes are expressed in mammalian tissues, COX-1 and COX-2. COX-1 is expressed constitutively in most tissues, whereas COX-2 is induced by various proinflammatory cytokines and mitogenic agents in different cell types and is thought to be responsible for the increased production of prostaglandins in inflammatory disorders (1). COX-2 synthesis is regulated primarily at the transcriptional level via distinct pathways in various cell types (including vascular endothelial cells, epithelial cells, pancreatic cells, mast cells, and monocytes) and involves transcription factors such as nuclear factor of chain in B cells (NF-B), activator protein-1 (AP-1), CCAAT/enhancer-binding protein (C/EBP), cAMP-responsive element-binding protein (CREB), and nuclear factor of activated T cells (NFAT) (2-10). COX-2 seems to act as an early T cell receptor (TCR)-responsive gene, because TCR engage...